1. “Complimenting the Complement”: Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma
   Astha Malik et al, 2021, Frontiers in Oncology CrossRef
2. The human factor H protein family – an update
   Noémi Sándor et al, 2024, Frontiers in Immunology CrossRef
3. Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma
   Rui Sun et al, 2021, Frontiers in Oncology CrossRef
4. Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
   Qinglin Ding et al, 2022, Frontiers in Oncology CrossRef
5. Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma
   Cuifang Han et al, 2023, Frontiers in Oncology CrossRef
6. Microarray data analysis of antileukemic action of Cinnamoylated benzaldehyde LQB-461 in Jurkat cell line
   Rachell R. C. Thimoteo et al, 2024, Molecular Biology Reports CrossRef
7. An update on the role of complement in hepatocellular carcinoma
   Zhijie Xiao et al, 2022, Frontiers in Immunology CrossRef
8. Innovative Dual mRNA-Lipid Nanoparticle Therapy Targeting CRHBP and CFHR3 for Enhanced Treatment of Hepatocellular Carcinoma
   Tianmei Fu et al, 2024, International Journal of Nanomedicine CrossRef